IRWD (STOCKS)
Ironwood Pharmaceuticals, Inc. - Class A
$4.124500
-0.195500 (-4.53%)
Prev close: $4.320000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas A. McCourt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $674.18M
- Employees
- 253
- P/E (TTM)
- 5.63
- P/B (TTM)
- -4.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.31 | $0.36 | -0.0531 | -14.62% |
|
Mar 2026 (Q1)
|
$0.24 | $0.24 | -0.0048 | -1.96% |
|
Dec 2025 (Q4)
|
$-0.01 | $0.01 | -0.0202 | -198.04% |
|
Sep 2025 (Q3)
|
$0.24 | $0.10 | +0.1380 | +135.29% |
Financial Statements
| Revenues | $389.32M |
| Benefits Costs and Expenses | $168.12M |
| Costs And Expenses | $155.15M |
| Nonoperating Income/Loss | -$26.79M |
| Operating Expenses | $155.15M |
| Selling, General, and Administrative Expenses | $64.55M |
| Research and Development | $88.69M |
| Operating Income/Loss | $234.17M |
| Income/Loss From Continuing Operations After Tax | $129.87M |
| Income/Loss From Continuing Operations Before Tax | $213.73M |
| Income Tax Expense/Benefit | $77.51M |
| Net Income/Loss | $129.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $129.87M |
| Net Income/Loss Available To Common Stockholders, Basic | $129.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.80 |
| Diluted Earnings Per Share | $0.77 |
| Basic Average Shares | 326,345,000 |
| Diluted Average Shares | 330,726,000 |
| Assets | $285.13M |
| Current Assets | $199.20M |
| Noncurrent Assets | $85.93M |
| Fixed Assets | $2.91M |
| Other Non-current Assets | $83.01M |
| Liabilities | $446.97M |
| Current Liabilities | $32.85M |
| Accounts Payable | $911.00K |
| Wages | $7.49M |
| Other Current Liabilities | $24.46M |
| Noncurrent Liabilities | $414.12M |
| Equity | -$161.84M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$161.84M |
| Liabilities And Equity | $285.13M |
| Net Cash Flow From Operating Activities | $185.56M |
| Net Cash Flow From Operating Activities, Continuing | $185.56M |
| Net Cash Flow From Investing Activities | $136.30M |
| Net Cash Flow From Investing Activities, Continuing | $136.30M |
| Net Cash Flow From Financing Activities | -$199.58M |
| Net Cash Flow From Financing Activities, Continuing | -$199.58M |
| Net Cash Flow | $122.28M |
| Net Cash Flow, Continuing | $122.28M |
| Comprehensive Income/Loss | $131.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $131.57M |
| Other Comprehensive Income/Loss | -$574.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $1.70M |